Ads
related to: what is sickle cell disease
Search results
Results From The WOW.Com Content Network
Pfizer bought Oxbryta, also known as voxelotor, as part of its $5.4 billion buyout of Global Blood Therapeutics in 2022. Pfizer is also discontinuing all studies and access programs related to the ...
Sickle cell disease affects an estimated 100,000 people in the U.S., most of whom are Black. The withdrawal is the latest headwind for Pfizer and its CEO Albert Bourla. Investors have punished the ...
One example she cites is the health care industry’s handling of sickle cell anemia, which 1 in 13 Black babies in the U.S. are born with, according to the Centers for Disease Control and Prevention.
Sickle cell trait causes a change in the haemoglobin molecule in the blood. Normally, red blood cells have a very flexible, biconcave shape that allows them to move through narrow capillaries ; however, when the modified haemoglobin S molecules are exposed to low amounts of oxygen, or crowd together due to dehydration, they can stick together ...
However, in systemic lupus erythematosus it is 4 to 14%, [106] and in sickle cell disease, it ranges from 20 to 40%. [107] Up to 4% of people who develop a pulmonary embolism go on to develop chronic thromboembolic disease including pulmonary hypertension. [ 40 ]
In 2023, the first drug making use of CRISPR gene editing, Casgevy, was approved for use in the United Kingdom to cure sickle-cell disease and beta thalassemia. [13] [14] Casgevy was approved for use in the United States on December 8, 2023, by the Food and Drug Administration. [15]